MedPath
HSA Approval

ACTRAPID PENFILL INJECTION 100 IU/ml

SIN02397P

ACTRAPID PENFILL INJECTION 100 IU/ml

ACTRAPID PENFILL INJECTION 100 IU/ml

November 24, 1988

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Regulatory Information

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Therapeutic

Pharmacy Only

Formulation Information

INJECTION

_**3\. How to use Actrapid®**_ Talk about your insulin needs with your doctor and nurse. Make sure you take Actrapid® Penfill® as instructed by your doctor or nurse and follow their advice carefully. If your doctor has switched you from one type or brand of insulin to another, your dose may have to be adjusted by your doctor. Eat a meal or snack containing carbohydrates within 30 minutes of the injection. It is recommended that you measure your blood sugar regularly. **How to use this insulin** **Actrapid® is administered by injection under the skin** (subcutaneously). Always vary the sites you inject within the same region, to reduce the risk of developing lumps or skin pitting (see _5 Possible side effects_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). The best places to give yourself an injection are: the front of your waist (abdomen); your buttocks; the front of your thighs or upper arms. Your insulin will work more quickly if you inject it around the waist. **How to inject this insulin** - **Inject the insulin** under the skin. Use the injection technique advised by your doctor or nurse and as described in your delivery system manual. - **Keep the needle under your skin** for at least 6 seconds. Keep the push-button fully depressed until the needle has been withdrawn. This will ensure correct delivery and limit possible flow of blood into the needle or insulin reservoir. - **After each injection** be sure to remove and discard the needle and store Actrapid® without the needle attached. Otherwise the liquid may leak out which can cause inaccurate dosing. Do not refill Actrapid® Penfill®. Penfill® cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine® or NovoTwist® needles. If you are treated with Actrapid® Penfill® and another insulin Penfill® cartridge, you should use two insulin delivery systems, one for each type of insulin. As a precautionary measure, always carry a spare insulin delivery system in case your Penfill® is lost or damaged.

SUBCUTANEOUS

Medical Information

_**1\. What Actrapid® is and what it is used for**_ **Actrapid® is human insulin used to treat diabetes.** Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of your blood sugar. Actrapid® is a fast-acting insulin. This means that it will start to lower your blood sugar about ½ hour after you take it, and the effect will last for approximately 8 hours. Actrapid® is often given in combination with longer-acting insulin products.

_**2\. Before you use Actrapid®**_ **Do not use Actrapid®** - **In insulin infusion pumps.** - **If you are allergic (hypersensitive)** to human insulin or any of the other ingredients in Actrapid® (see _7 Further information_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - **If you suspect hypoglycaemia** (low blood sugar) is starting (see _4 What to do in an emergency_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - **If the cartridge or the device containing the cartridge is dropped, damaged or crushed.** - **If it has not been stored correctly** or been frozen (see _6 How to store Actrapid®_ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). - **If the insulin does not appear clear and colourless.**

A10AB01

insulin (human)

Manufacturer Information

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Novo Nordisk A/S

Novo Nordisk Producao Farmaceutica do Brasil Ltda

Novo Nordisk Production SAS

Active Ingredients

INSULIN HUMAN, rDNA

100 iu/ml

Insulin human

Documents

Patient Information Leaflets

Actrapid Injection (Penfill) PIL.pdf

Approved: February 4, 2022

Download
© Copyright 2025. All Rights Reserved by MedPath
ACTRAPID PENFILL INJECTION 100 IU/ml - HSA Approval | MedPath